Combining ALA with Letrozole for treating infertility in women with PCOS
Official title: Effect of Alpha-Lipoic Acid Supplementation on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females Treated With Letrozole
Run by Ain Shams University · NCT06418347 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if adding Alpha lipoic acid (ALA) to letrozole can help women with PCOS who are struggling with infertility get pregnant more effectively.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 2 sites (Cairo and 1 other locations) |
| Trial ID | NCT06418347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18-35 diagnosed with PCOS and experiencing infertility for at least one year.
✕Probably not a fit
Patients with infertility due to factors other than PCOS or those with contraindications to pregnancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of adding Alpha lipoic acid (ALA) to letrozole treatment in women with polycystic ovary syndrome (PCOS) who are experiencing infertility. A total of 150 participants will be randomly assigned to either a control group receiving letrozole alone or an intervention group receiving letrozole along with ALA supplements. The study will monitor the participants' ovulation rates and overall clinical outcomes through trans-vaginal ultrasound scans and follow standard PCOS care protocols. The goal is to determine if the addition of ALA enhances fertility outcomes compared to letrozole alone.
Why it matters
Potential benefit: If successful, this approach could improve fertility rates in women with PCOS.
How similar studies have gone: While the combination of ALA and letrozole is a novel approach, previous studies have shown that letrozole is effective for treating infertility in PCOS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patient aged 18-35 * Willing to conceive * PCOS, diagnosed according to the revised 2003 Rotterdam consensus criteria. " Oligo- or anovulation secondary to PCOS and at least one of the remaining two criteria: hyperandrogenism or polycystic ovarian morphology on ultrasound . * Anovulation and/or infertility ≥ 1 year. * At least one patent fallopian tube * Normal uterine cavity * Male partner with sperm concentration of at least 14 million/mL in at least one ejaculate. Exclusion Criteria: * Other causes for the infertility (male factor, tubal factor). * Intake of hormonal or other drugs that can potentially influence the ovulation. * Causes of anovulation or hyperandrogenism other than PCOS such as uncontrolled thyroid dysfunction or hyperprolactinemia. * Contraindication to pregnancy * Myo-inositol use \< 3 months prior to study enrollment * Concomitant metformin use. Previous use is allowed with last use at least 6 weeks prior to randomization.
Where it's running
-
Ain shams university
Cairo, Egypt Recruiting -
Ain shams university
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Muoaz A. Sallam, Teaching assistance
- Email: Moaaz.ahmed22@pharma.asu.edu.eg
- Phone: +0201102174081
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating mitochondrial dysfunction in women with PCOS and infertility
This study is trying to see if problems with energy production in cells are linked to polycystic ovary syndrome (PCOS) and infertility in women.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Precision acupuncture and lifestyle for PCOS
This trial tests whether a precision acupuncture approach combined with a personalized lifestyle plan helps improve insulin resistance in people with PCOS compared with conventional acupuncture and standard lifestyle changes.
-
Orlistat for metabolic and hormonal features in women with PCOS
This trial tests whether adding orlistat to lifestyle advice helps improve metabolic and hormonal aspects in women with PCOS compared to lifestyle advice alone.
-
Physical activity program for women with PCOS and fatty pancreas plus subclinical hypothyroidism
A program of exercise is being tested to see if it helps women with PCOS who also have fatty pancreas and subclinical hypothyroidism, compared to usual care.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.